ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹9.31 Cr | ₹5.36 Cr | ₹5.43 Cr | ₹13 Cr | ₹11 Cr |
What is the latest Contingent Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹9.31 Cr |
| Mar2024 | ₹5.36 Cr |
| Mar2023 | ₹5.43 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹11 Cr |
How is Contingent Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.31 Cr | 73.70 | |
| Mar2024 | ₹5.36 Cr | -1.40 | |
| Mar2023 | ₹5.43 Cr | -58.47 | |
| Mar2022 | ₹13 Cr | 15.98 | |
| Mar2021 | ₹11 Cr | - | |
Compare Contingent Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,009.6 Cr | -2.4% | -12% | -20% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -2.4% |
-12% |
-20% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses